Krystal Biotech, Inc. KRYS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s investing cash flow?
- Krystal Biotech, Inc. (KRYS) reported investing cash flow of -$63.58M in Q1 2026.
- How has Krystal Biotech, Inc.'s investing cash flow changed year-over-year?
- Krystal Biotech, Inc.'s investing cash flow decreased by 16.1% year-over-year, from -$54.77M to -$63.58M.
- What is the long-term trend for Krystal Biotech, Inc.'s investing cash flow?
- Over 2 years (2021 to 2024), Krystal Biotech, Inc.'s investing cash flow has grown at a -15.1% compound annual growth rate (CAGR), from -$226.77M to -$163.44M.
- What does investing cash flow mean?
- The net result of all cash spent on and received from investments and assets.
- How do you interpret investing cash flow?
- Negative values are typical for growing companies investing in infrastructure or securities, while positive values may indicate asset liquidation.
- How does investing cash flow compare across companies?
- Varies widely based on the company's stage of development and current capital expenditure cycle.